Results 21 to 30 of about 198,836 (264)

Circadian Variation of Migraine Attack Onset Affects fMRI Brain Response to Fearful Faces

Frontiers in Human Neuroscience, 2022
BackgroundPrevious studies suggested a circadian variation of migraine attack onset, although, with contradictory results – possibly because of the existence of migraine subgroups with different circadian attack onset peaks. Migraine is primarily a brain
Daniel Baksa, Daniel Baksa, Daniel Baksa, Edina Szabo, Edina Szabo, Edina Szabo, Natalia Kocsel, Natalia Kocsel, Attila Galambos, Attila Galambos, Andrea Edit Edes, Andrea Edit Edes, Dorottya Pap, Terezia Zsombok, Mate Magyar, Mate Magyar, Mate Magyar, Kinga Gecse, Kinga Gecse, Dora Dobos, Dora Dobos, Lajos Rudolf Kozak, Gyorgy Bagdy, Gyorgy Bagdy, Gyorgy Bagdy, Gyongyi Kokonyei, Gyongyi Kokonyei, Gyongyi Kokonyei, Gabriella Juhasz, Gabriella Juhasz, Gabriella Juhasz, Gabriella Juhasz   +31 more
doaj   +1 more source

The Migraine Stigma Kaleidoscope View

Neurology and Therapy, 2023
The stigma of migraine, despite an impressive body of data on the epidemiological of migraine and the associated disability, burden and cost of migraine to patients, has not been fully evaluated as an important factor in the chronicization of the disease
Elena Gross, Elena Ruiz de la Torre, Paolo Martelletti   +2 more
doaj   +1 more source

Regular Practice of Autogenic Training Reduces Migraine Frequency and Is Associated With Brain Activity Changes in Response to Fearful Visual Stimuli

Frontiers in Behavioral Neuroscience, 2022
Several factors can contribute to the development and chronification of migraines, including stress, which is undoubtedly a major trigger. Beyond pharmacotherapy, other treatment methods also exist, including behavioral techniques aiming at reducing ...
Dóra Dobos, Dóra Dobos, Edina Szabó, Edina Szabó, Edina Szabó, Dániel Baksa, Dániel Baksa, Kinga Gecse, Kinga Gecse, Natália Kocsel, Natália Kocsel, Dorottya Pap, Terézia Zsombók, Lajos R. Kozák, Gyöngyi Kökönyei, Gyöngyi Kökönyei, Gyöngyi Kökönyei, Gabriella Juhász, Gabriella Juhász, Gabriella Juhász, Gabriella Juhász   +20 more
doaj   +1 more source

SCN 1A /Na V 1.1 channelopathies: Mechanisms in expression systems, animal models, and human iPSC models [PDF]

Epilepsia, Wiley, 2019, 60 (S3), 2022
Pathogenic SCN1A/NaV1.1 mutations cause well defined epilepsies, including Genetic Epilepsy with Febrile Seizures Plus (GEFS+) and the severe epileptic encephalopathy Dravet syndrome. In addition, they cause a severe form of migraine with aura, Familial Hemiplegic Migraine.
arxiv   +1 more source

Depressive symptoms are correlated with periaqueductal gray matter functional connectivity in migraine

European Psychiatry, 2022
Introduction Depression is the most common comorbidity of migraine. The brain of migraineurs with depression shows differences compared to migraine only or depression only patients.
K. Gecse, D. Dobos, N. Károlyi, D. Baksa, C.S. Aranyi, M. Emri, G. Kökönyei, G. Bagdy, G. Juhasz   +8 more
doaj   +1 more source

Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study

The Journal of Headache and Pain, 2021
Background Chronic migraine (CM) is associated with substantial economic burden. Real-world data suggests that onabotulinumtoxinA treatment for CM reduces healthcare resource utilisation (HRU) and related costs.
Katja Kollewe, Charly Gaul, Astrid Gendolla, Katherine Sommer   +3 more
doaj   +1 more source

Spontaneous migraine attack causes alterations in default mode network connectivity: a resting-state fMRI case report

BMC Research Notes, 2017
Background Although migraine is one of the most investigated neurologic disorders, we do not have a perfect neuroimaging biomarker for its pathophysiology.
Andrea Edit Edes, Lajos Rudolf Kozak, Mate Magyar, Terezia Zsombok, Gyongyi Kokonyei, Gyorgy Bagdy, Gabriella Juhasz   +6 more
doaj   +1 more source

Atogepant for the Preventive Treatment of Migraine.

New England Journal of Medicine, 2021
BACKGROUND Atogepant is an oral, small-molecule, calcitonin gene-related peptide receptor antagonist that is being investigated for the preventive treatment of migraine. METHODS In a phase 3, double-blind trial, we randomly assigned adults with 4 to 14
J. Ailani, R. Lipton, P. Goadsby, Hua Guo, R. Miceli, L. Severt, M. Finnegan, Joel M. Trugman   +7 more
semanticscholar   +1 more source

Sinonasal symptoms in migraine without aura: results from the cross-sectional ‘Migraine in Poland’ study

Frontiers in Neurology, 2023
BackgroundMigraine without aura (MwoA) is often mistaken for rhinosinusitis. The purpose of this study was to assess the prevalence of sinonasal symptoms, sinusitis-targeting medication use and burden of migraine in a large group of people with MwoA ...
Marcin Straburzynski, Magdalena Nowaczewska, Ewa K. Czapinska-Ciepiela, Anna Gryglas-Dworak, Slawomir Budrewicz, Marta Waliszewska-Prosół   +5 more
doaj   +1 more source

Migraine pharmacology and brain ischemia [PDF]

Research Results in Pharmacology, 2021
Introduction: The aim of this review article was to analyze in details the mechanism of drugs’ effects in the treatment and prevention of a migraine attack, as well as to discuss the hypotheses of migraine pathogenesis.
Ruben S. Mirzoyan, Tamara S. Gan’shina, Ilya N. Kurdyumov, Denis V. Maslennikov, Anna V. Gnezdilova, Alexander A. Gorbunov, Elena V. Kursa, Antonina I. Turilova, Leonid M. Kostochka, Narine R. Mirzoyan   +9 more
doaj   +3 more sources